Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May;56(3):382-385.
doi: 10.1007/s43441-022-00378-0. Epub 2022 Feb 11.

Ivermectin in COVID-19: The Case for a Moratorium on Prescriptions

Andreea Molnar  1 , Stephanie Lau  2 , Maja Berges  2 , Raymond B Masa  3 , Joshua J Solano  4 , Scott M Alter  4 , Lisa M Clayton  4 , Richard D Shih  4 , David L DeMets  5 , Dennis G Maki  5 , Charles H Hennekens  5
Affiliations

Ivermectin in COVID-19: The Case for a Moratorium on Prescriptions

Andreea Molnar et al. Ther Innov Regul Sci. 2022 May.

Abstract

In treatment or prevention of COVID-19, ivermectin is not approved by the United States (US) Food and Drug Administration (FDA). Nonetheless, in the US, prescriptions of ivermectin by healthcare providers have increased > tenfold from 3589 per week pre-COVID-19 to 39,102. Ivermectin is FDA approved for animals to treat parasites and for humans to treat intestinal strongyloidiasis and onchocerciasis orally, and ectoparasites and skin conditions topically. It is not a benign drug, with reported side effects including cutaneous, gastrointestinal, and cardiovascular symptoms. The evidence to support ivermectin to treat or prevent COVID-19 includes some basic research and inconsistent clinical observations that contribute to the formulation of a hypothesis of efficacy in COVID-19. At present, data from peer-reviewed published randomized trials of sufficient size, dose, and duration to reliably test the hypothesis of the most plausible small to moderate benefits on clinically relevant endpoints are sparse. In addition to the US FDA, the US National Institutes of Health, World Health Organization, and European Medicines Agency have all advised against ivermectin for treatment or prevention of COVID-19 outside of randomized trials. For ivermectin in treatment or prevention of COVID-19, healthcare providers should reassure all patients that if sufficient evidence were to emerge, then this drug could be considered a therapeutic innovation and regulatory authorities would approve the drug. In the meanwhile, we strongly recommend a moratorium on the prescription of ivermectin for the treatment or prevention of COVID-19 except in randomized trials to provide the most reliable test of the hypothesis.

Keywords: COVID-19; Ivermectin; Prescription moratorium; Randomized trials; Regulatory science; Therapeutic innovation.

PubMed Disclaimer

Conflict of interest statement

Dr. Molnar, Dr. Lau, Ms. Berges, Mr. Masa, Dr. Solano, Dr. Alter, Dr. Clayton, and Professors Shih and Maki have no disclosures.

References

    1. United States Food and Drug Administration. Why you should not use Ivermectin to treat or prevent COVID-19 patients. https://www.fda.gov/consumers/consumer-updates/why-you-should-not-use-iv.... Published March 5, 2021. Accessed November 22, 2021.
    1. Lind JN, Lovegrove MC, Geller AI, Uyeki TM, Datta SD, Budnitz DS. Increase in outpatient ivermectin dispensing in the us during the covid-19 pandemic: a cross-sectional analysis. J Gen Intern Med. 2021;36(9):2909–2911. doi: 10.1007/s11606-021-06948-6. - DOI - PMC - PubMed
    1. Zaidi AK, Dehgani-Mobaraki P. The mechanisms of action of Ivermectin against SARS-CoV-2: An evidence-based clinical review. J Antibiot (Tokyo) 2021 doi: 10.1038/s41429-021-00430-5. - DOI - PMC - PubMed
    1. National Institutes of Health COVID treatment guidelines: Ivermectin Updated February 21, 2021. https://www.covid19treatmentguidelines.nih.gov/therapies/antiviral-thera.... Accessed November 22, 2021.
    1. National Institutes of Health. Prevention and Prophylaxis of SARS-CoV-2 Infection. https://www.covid19treatmentguidelines.nih.gov/overview/prevention-of-sa.... Last updated July 8, 2021.

LinkOut - more resources